Although the clinical administration of this therapy can bring significant efficacy and survival improvement for these patients, its efficacy is closely related to the expression of PD-L1 [3], tumor mutation burden [6], neutrophil/lymphocyte ratio [7], and body mass index [8]. Here, CD274 is linked to neoplasm.